BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Knickelbein JE, Armbrust KR, Kim M, Sen HN, Nussenblatt RB. Pharmacologic Treatment of Noninfectious Uveitis. Handb Exp Pharmacol 2017;242:231-68. [PMID: 27848029 DOI: 10.1007/164_2016_21] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Kumar B, Cashman SM, Kumar-Singh R. Complement-Mediated Activation of the NLRP3 Inflammasome and Its Inhibition by AAV-Mediated Delivery of CD59 in a Model of Uveitis. Mol Ther 2018;26:1568-80. [PMID: 29678656 DOI: 10.1016/j.ymthe.2018.03.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
2 Wang F, Jiang Z, Lou B, Duan F, Qiu S, Cheng Z, Ma X, Yang Y, Lin X. αB-Crystallin Alleviates Endotoxin-Induced Retinal Inflammation and Inhibits Microglial Activation and Autophagy. Front Immunol 2021;12:641999. [PMID: 33777038 DOI: 10.3389/fimmu.2021.641999] [Reference Citation Analysis]
3 Esatoglu SN, Hatemi G. Update on the treatment of Behçet's syndrome. Intern Emerg Med 2019;14:661-75. [PMID: 30684097 DOI: 10.1007/s11739-019-02035-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
4 Paiva MRB, Vasconcelos-Santos DV, Coelho MM, Machado RR, Lopes NP, Silva-Cunha A, Fialho SL. Licarin A as a Novel Drug for Inflammatory Eye Diseases. J Ocul Pharmacol Ther 2021;37:290-300. [PMID: 33761287 DOI: 10.1089/jop.2020.0129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]